Originally published by our sister publication Gastroenterology & Endoscopy News
By Natasha Albaneze
CHARLOTTE, N.C.—Many major insurance companies do not adhere to the most recent recommendations on inflammatory bowel disease treatment from the American College of Gastroenterology and the American Gastroenterological Association, according to an analysis of insurance company policies.
The study, conducted by researchers at Beth Israel Deaconess Medical Center, in Boston, analyzed